These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24670455)

  • 1. [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].
    Li H; Gao F; Xue Y; Qian Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):387-90. PubMed ID: 24670455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
    Am J Cardiol; 2014 Sep; 114(6):890-4. PubMed ID: 25073564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Differentiation Factor 15 and Matrix Metalloproteinase 3 in Plasma as Biomarkers for Neuropathy and Nephropathy in Type 1 Diabetes.
    Billeson K; Baldimtsi E; Wahlberg J; Whiss PA
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
    Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
    Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.
    Yano Y; Kitagawa N; Gabazza EC; Morioka K; Urakawa H; Tanaka T; Katsuki A; Araki-Sasaki R; Hori Y; Nakatani K; Taguchi O; Sumida Y; Adachi Y
    J Clin Endocrinol Metab; 2003 Feb; 88(2):736-41. PubMed ID: 12574207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
    Galovičová A; Lazúrová I; Petrášová D
    Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma osteoprotegerin level and osteoprotegerin expression in renal biopsy tissue are increased in type 2 diabetes with nephropathy.
    Wang ST; Zhang CY; Zhang CM; Rong W
    Exp Clin Endocrinol Diabetes; 2015 Feb; 123(2):106-11. PubMed ID: 25502845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST; Xu JM; Wang M; Chen FL; Ding G
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease.
    Ay L; Hoellerl F; Ay C; Brix JM; Koder S; Schernthaner GH; Pabinger I; Schernthaner G
    Eur J Clin Invest; 2012 May; 42(5):470-7. PubMed ID: 21955218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.